trial · primary record
Allogeneic Bone-Marrow Derived Mesenchymal Stromal Cells Secretome
Persistent Corneal Epithelial Defect
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 24 |
| Primary completion | 2026-12-15 |
| Primary endpoint | Improvement of Corneal Epithelial Barrier and/or Integrity (Efficacy Outcome) |
| Registry ID | NCT06919081 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:38:26.570Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06919081
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.